Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07179406 · ClinicalTrials.gov registry record · NA
The Effect of Spinal Cord Stimulators on Restless Leg Syndrome
A NA study of Restless Leg Syndrome (RLS) and Spinal Cord Stimulation (SCS), sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07179406: Recruiting NA study of Restless Leg Syndrome (RLS) and Spinal Cord Stimulation (SCS), sponsored by University of Alabama at Birmingham.
NCT07179406 is a NA study of Restless Leg Syndrome (RLS) and Spinal Cord Stimulation (SCS) that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07179406, a NA study of Restless Leg Syndrome (RLS) and Spinal Cord Stimulation (SCS), is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate neurophysiological responses and symptom changes in individuals with Restless Legs Syndrome (RLS) and/or chronic pain. Participants will undergo standard clinical assessments including EEG, EMG, h-reflex, SSEP, ERP, and TMS under varying SCS conditions.The study involves 4 arms. Arm 1 are individuals diagnosed with RLS and Healthy Controls. Arm 2 are individuals diagnosed with RLS and have an existing SCS. Arm 3 are individuals diagnosed with RLS and scheduled to receive a SCS. Arm 4 are individuals with chronic pain and have a SCS, but no diagnosis of RLS.
Conditions Studied
Interventions
- OTHER H-Reflex
- OTHER Somatosensory evoked potential (SSEP)
- OTHER Vibratory Electrophysiological Response Potential (ERP)
- OTHER Transcranial Magnetic Stimulation (TMS)
- OTHER Spinal Cord Stimulator (SCS) manipulation
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-08-04 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT07179406 shows while recruiting
NCT07179406 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Restless Leg Syndrome (RLS) appearing as the primary indexed condition, and to 5 interventions - of which H-Reflex is the first listed.
NCT07179406 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT07179406 about?
NCT07179406 is a clinical study titled "The Effect of Spinal Cord Stimulators on Restless Leg Syndrome". This study aims to evaluate neurophysiological responses and symptom changes in individuals with Restless Legs Syndrome (RLS) and/or chronic pain. Participants will undergo standard clinical assessments including EEG, EMG, h-reflex, SSEP, ERP, and TMS under varying SCS conditions.The study involves ...
What is the current status of trial NCT07179406?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-08-04. Estimated completion is 2028-12-31.
What conditions does trial NCT07179406 study?
This clinical trial studies the following conditions: Restless Leg Syndrome (RLS), Spinal Cord Stimulation (SCS).
What interventions are being tested in trial NCT07179406?
The interventions under investigation include: H-Reflex (OTHER), Somatosensory evoked potential (SSEP) (OTHER), Vibratory Electrophysiological Response Potential (ERP) (OTHER), Transcranial Magnetic Stimulation (TMS) (OTHER), Spinal Cord Stimulator (SCS) manipulation (OTHER).
Who is sponsoring clinical trial NCT07179406?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07179406 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Restless Leg Syndrome (RLS)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07179406's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI